Keywords: China, Western treatments, Bayer, Nexavar, Liver caner, Eli Lilly, Alimta, NSCLC, Kantar Health, Draco Healthcare

Nexavar use in Chinese patients nearly doubled in 2012

Article | 19 December 2012

Use of Nexavar (sorafenib, from Bayer [BAYN: DE] and Onyx Pharmaceuticals) has nearly doubled in first-line advanced hepatocellular carcinoma (HCC) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Eli Lilly

Go to company listing

Related Drugs

Nexavar

Alimta

Go to drug listing